Seeking Alpha

Regulus Therapeutics (RGLS) looks set for another painful session (-12% Tuesday) after pricing...

Regulus Therapeutics (RGLS) looks set for another painful session (-12% Tuesday) after pricing its 4.5M share public offering at $9.50, some 11% lower than yesterday's close. Shares -7.76% premarket. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|